Abstract: Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

Abstract: A protective case for use with a portable electronic device includes a protective shell and a cap. The protective shell is configured to at least partially encase the portable electronic device and includes an aperture configured to align with a receptacle of the portable electronic device when the portable electronic device is installed in the protective case. The aperture is configured to allow insertion of the stylus into the receptacle of the portable electronic device from outside the protective shell a cap removably insertable into the aperture of the protective shell to close the aperture. The cap is attachable to the stylus to facilitate removal of the stylus from the receptacle of the installed portable electronic device. The cap is configured to allow the stylus to extend into the receptacle to interact with the sensor of the portable electronic device while remaining attached to the stylus.

Abstract: A waterproof protective case comprising a shell that at least partially encloses a portable electronic device, the shell having an aperture aligned with an opening of a storage area of the portable electronic device, the protective case including a cap that is removably attached to a stylus of the portable electronic device, the aperture of the shell configured to releasably retain a portion of the cap when the stylus is inserted into the opening of the storage area of the portable electronic device, the cap configured to form a waterproof seal when the cap is retained within the aperture of the shell, the cap configured to remove the stylus from the storage area of the protective electronic device while the portable electronic device is in the waterproof protective case.

Abstract: A product including a package is provided. One or more tobacco-containing articles may be received in the package. A power producer may be configured to produce an electrical current. An output mechanism may be configured to receive the electrical current from the power producer and output a perceptible effect. The perceptible effect may, for example, increase a consumer's interest in the product. A related method is also provided.

Abstract: An electronic single-space parking meter mechanism is provided. The electronic single-space parking meter mechanism includes an inner housing having a front side and a rear side. The meter mechanism includes wireless communications hardware including an antenna. The meter mechanism includes a payment reader supported by the inner housing and an electronic display screen supported by the inner housing. At least a portion of the antenna is located above at least a portion of the electronic display screen.

Abstract: A single space electronic parking meter mechanism for inserting into an outer parking meter housing is provided. The mechanism includes an inner housing, a payment receiving structure supported by the inner housing and an electronic display screen supported by the inner housing. The mechanism also includes a wireless communication subsystem supported by the inner housing configured to wirelessly communicate with a parking management system and an electronic meter control system controlling the electronic display and the wireless communications subsystem. The mechanism includes a memory device receiving port externally accessible through the inner housing and a read-write removable memory device physically accessible from outside of the inner housing and configured to be coupled to the memory device receiving port. The removable memory device including operation mode information that is read by the electronic meter control system to select an operation mode of the meter mechanism.

Abstract: Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

Abstract: A waterproof protective case comprising a shell that at least partially encloses a portable electronic device, the shell having an aperture aligned with an opening of a storage area of the portable electronic device, the protective case including a cap that is removably attached to a stylus of the portable electronic device, the aperture of the shell configured to releasably retain a portion of the cap when the stylus is inserted into the opening of the storage area of the portable electronic device, the cap configured to form a waterproof seal when the cap is retained within the aperture of the shell, the cap configured to remove the stylus from the storage area of the protective electronic device while the portable electronic device is in the waterproof protective case.

Abstract: A solution to mitigate organizational risks and exposure from damages and harm related to distracted driving. The invention includes a system, method, and devices that enable the organization to manage, monitor, and enforce corporate Mobile Device policies, in particular policies to deter and prevent distracted driving and encourage safe alternatives. A system for preventing distracted driving, including an Organizational Policy for anti-distracted driving including a rule and a Mobile Device configured to restrict, disable, or enable a feature of the Mobile Device based upon the rule.

Abstract: An accessory device (20) for a stroller has a body (42) with a central portion (44) between opposed free ends (46) of the body and has an infant car seat mount (120) carried on the body (42) near at least one of the free ends of the body (42). The accessory device (20) is configured to at least partially widthwise traverse a frame assembly of a stroller (10) when installed on the frame assembly. The accessory device (20) is selectively removable from and attachable to the frame assembly, whereby the infant car seat mount (120) is also removable from and attachable relative to the frame assembly in concert with the accessory device.

Abstract: Polymorphic forms of Compound (1) or a pharmaceutically acceptable salt thereof, wherein Compound (1) is represented by the following structural formula: are Form A of HCl salt of Compound (1).½H2O, Form F of HCl salt of Compound (1).3H2O, Form D of HCl salt of Compound (1), Form A of Compound (1), and Form A of tosylate salt of Compound (1). Such polymorphic forms are employed for treating influenza, inhibiting the replication of influenza viruses, or reducing the amount of influenza viruses in a biological sample or in a subject.

Abstract: A solution to mitigate personal, organizational, and network wide risks and exposure from damages and harm related to distracted driving. The invention includes a system, method, and devices that enforce a safe messaging protocol that prevents communications from being transmitted to recipients while the recipients are driving, piloting, operating heavy machinery or otherwise endangered from being distracted from incoming communications.

Abstract: Analyte separation systems for use in conjunction with chromatography separation devices and techniques are described. Disclosed systems include modular components that can provide for individualized design of separation schemes to better fit the needs of the user. In addition, the systems can be automated for efficient use of time. The system can include a mixing module for combination of fractions with an agent that can improve the recovery of the analyte from the fraction. Other modules can remove materials from the fluid flow through the system as waste or for recapture. Additional modules can be combined so as to provide parallel processing of multiple streams, which can further improve efficiency of the system.

Abstract: Described herein are a number of Ebola monoclonal antibodies.

Abstract: Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

Abstract: The present application is directed to a combination effect pigment comprising a platy substrate, an outer layer disposed above the platy substrate, and carbon black, wherein the carbon black is disposed above the substrate and is entrapped by the outer layer.

Abstract: The present application is directed to combination effect pigments comprising an effect pigment and carbon black, wherein the carbon black is adherently deposited on the effect pigment interposed within the substrate and at least one subsequent layer of the effect pigment. This structure of the combination effect pigment results in advantageous non-staining properties of the pigment and maximizes color effects of the carbon black.

Abstract: Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

Abstract: A blank configured to form a package is provided. The blank may include a bottom panel, a top panel, and an overlapping panel having an edge region and an adjoining region positioned between the edge region and the top panel. The adjoining region of the overlapping panel overlaps and attaches to the bottom panel to form a compartment when formed into a package. The compartment may be employed to store a consumable product, such as cartridges for an aerosol delivery device. A related method for forming the blank into the package is also provided.